Insider Buy/Sell Details for the Biotechnology Industry — Last 7 Days
Ratio0.5:1
Daily Buy & Sell Volume
Transactions (298)
UNITED THERAPEUTICS Corp (UTHR)
ROTHBLATT MARTINE A — Director
Shares
359
Price
$479.67
Total Value
$172.20K
Shares Held After
332,024
% of Holdings
0.1%
UNITED THERAPEUTICS Corp (UTHR)
ROTHBLATT MARTINE A — Director
Shares
650
Price
$478.47
Total Value
$311.00K
Shares Held After
332,383
% of Holdings
0.2%
UNITED THERAPEUTICS Corp (UTHR)
ROTHBLATT MARTINE A — Director
Shares
749
Price
$477.43
Total Value
$357.59K
Shares Held After
333,033
% of Holdings
0.2%
UNITED THERAPEUTICS Corp (UTHR)
ROTHBLATT MARTINE A — Director
Shares
161
Price
$476.14
Total Value
$76.66K
Shares Held After
333,782
% of Holdings
0.0%
UNITED THERAPEUTICS Corp (UTHR)
ROTHBLATT MARTINE A — Director
Shares
207
Price
$554.70
Total Value
$114.82K
Shares Held After
324,443
% of Holdings
0.1%
UNITED THERAPEUTICS Corp (UTHR)
ROTHBLATT MARTINE A — Director
Shares
113
Price
$553.78
Total Value
$62.58K
Shares Held After
324,650
% of Holdings
0.0%
UNITED THERAPEUTICS Corp (UTHR)
ROTHBLATT MARTINE A — Director
Shares
120
Price
$552.63
Total Value
$66.32K
Shares Held After
324,763
% of Holdings
0.0%
UNITED THERAPEUTICS Corp (UTHR)
ROTHBLATT MARTINE A — Director
Shares
160
Price
$551.50
Total Value
$88.24K
Shares Held After
324,883
% of Holdings
0.0%
UNITED THERAPEUTICS Corp (UTHR)
ROTHBLATT MARTINE A — Director
Shares
400
Price
$550.47
Total Value
$220.19K
Shares Held After
325,043
% of Holdings
0.1%
UNITED THERAPEUTICS Corp (UTHR)
ROTHBLATT MARTINE A — Director
Shares
240
Price
$549.40
Total Value
$131.86K
Shares Held After
325,443
% of Holdings
0.1%
UNITED THERAPEUTICS Corp (UTHR)
ROTHBLATT MARTINE A — Director
Shares
280
Price
$548.25
Total Value
$153.51K
Shares Held After
325,683
% of Holdings
0.1%
UNITED THERAPEUTICS Corp (UTHR)
ROTHBLATT MARTINE A — Director
Shares
400
Price
$547.29
Total Value
$218.92K
Shares Held After
325,963
% of Holdings
0.1%
Rapport Therapeutics, Inc. (RAPP)
Gault Cheryl — Chief Operating Officer
Shares
2,075
Price
$33.76
Total Value
$70.04K
Shares Held After
139,914
% of Holdings
1.5%
Rapport Therapeutics, Inc. (RAPP)
Gault Cheryl — Chief Operating Officer
Shares
7,925
Price
$33.04
Total Value
$261.81K
Shares Held After
141,989
% of Holdings
5.3%
Adlai Nortye Group Ltd. (ANL)
Ji Ping — Director
Shares
5,000
Price
$15.95
Total Value
$79.75K
Shares Held After
121,453
% of Holdings
4.0%
Adlai Nortye Group Ltd. (ANL)
Ji Ping — Director
Shares
5,000
Price
$16.03
Total Value
$80.15K
Shares Held After
126,453
% of Holdings
3.8%
Xenon Pharmaceuticals Inc. (XENE)
MORTIMER IAN — Director
Shares
30,000
Price
$37.38
Total Value
$1.12M
Shares Held After
49,923
% of Holdings
60.1%
Xenon Pharmaceuticals Inc. (XENE)
Kelly Thomas Patrick — Chief Financial Officer
Shares
15,000
Price
$37.32
Total Value
$559.74K
Shares Held After
15,000
% of Holdings
100.0%
FILANA THERAPEUTICS, INC. (FLNA)
Barry Richard — Director
Shares
100,000
Price
$0.92
Total Value
$92.00K
Shares Held After
1,337,964
% of Holdings
7.5%
BioNTech SE (BNTX)
Sahin Ugur — Chief Executive Officer
Shares
32,000
Price
$98.12
Total Value
$3.14M
Shares Held After
214,209
% of Holdings
13.0%
Anixa Biosciences Inc (ANIX)
Catelani Michael — President, COO,&CFO
Shares
5,500
Price
$2.84
Total Value
$15.62K
Shares Held After
50,000
% of Holdings
11.0%
Hepion Pharmaceuticals, Inc. (HEPA)
Fisher Danina — Director
Shares
200,000
Price
$0.05
Total Value
$10.00K
Shares Held After
200,000
% of Holdings
100.0%
Alto Neuroscience, Inc. (ANRO)
Smith Nicholas Conrad — PRESIDENT AND CFO
Shares
110,830
Price
$26.58
Total Value
$2.95M
Shares Held After
24,060
% of Holdings
82.2%
Helus Pharma Inc. (HELP)
Cavers Greg — Chief Financial Officer
Shares
3,000
Price
$12.91
Total Value
$38.73K
Shares Held After
3,000
% of Holdings
100.0%
Lipocine Inc. (LPCN)
Higuchi John W. — Director
Shares
9,037
Price
$2.15
Total Value
$19.43K
Shares Held After
225,395
% of Holdings
4.0%
Revolution Medicines, Inc. (RVMD)
Sandler Alan B. — Chief Development Officer
Shares
301
Price
$204.72
Total Value
$61.62K
Shares Held After
52,559
% of Holdings
0.6%
Revolution Medicines, Inc. (RVMD)
Sandler Alan B. — Chief Development Officer
Shares
1,199
Price
$203.91
Total Value
$244.48K
Shares Held After
52,860
% of Holdings
2.2%
Revolution Medicines, Inc. (RVMD)
Sandler Alan B. — Chief Development Officer
Shares
1,000
Price
$202.81
Total Value
$202.81K
Shares Held After
54,059
% of Holdings
1.8%
Revolution Medicines, Inc. (RVMD)
Sandler Alan B. — Chief Development Officer
Shares
1,609
Price
$201.72
Total Value
$324.57K
Shares Held After
55,059
% of Holdings
2.8%
Revolution Medicines, Inc. (RVMD)
Sandler Alan B. — Chief Development Officer
Shares
2,200
Price
$200.82
Total Value
$441.80K
Shares Held After
56,668
% of Holdings
3.7%
Maze Therapeutics, Inc. (MAZE)
Dandekar Atul — CSBO
Shares
7,500
Price
$27.06
Total Value
$202.92K
Shares Held After
32,316
% of Holdings
18.8%
Grace Therapeutics, Inc. (GRCE)
Opaleye Management Inc. — 10% Owner
Shares
7,849
Price
$2.09
Total Value
$16.40K
Shares Held After
2,798,167
% of Holdings
0.3%
Legend Biotech Corp (LEGN)
Sanders Corazon (Corsee) D. — Director
Shares
27,370
Price
$9.46
Total Value
$258.92K
Shares Held After
52,731
% of Holdings
34.2%
Adlai Nortye Group Ltd. (ANL)
Ji Ping — Director
Shares
214
Price
$15.77
Total Value
$3.37K
Shares Held After
131,453
% of Holdings
0.2%
FILANA THERAPEUTICS, INC. (FLNA)
Barry Richard — Director
Shares
206,813
Price
$0.90
Total Value
$186.13K
Shares Held After
1,237,964
% of Holdings
16.7%
BioCardia, Inc. (BCDA)
Altman Peter — Director
Shares
1,000
Price
$1.03
Total Value
$1.03K
Shares Held After
384,885
% of Holdings
0.3%
PROTHENA CORP PUBLIC LTD CO (PRTA)
SCULLY WILLIAM P — 10% Owner
Shares
162,000
Price
$8.68
Total Value
$1.41M
Shares Held After
214,000
% of Holdings
75.7%
UNITED THERAPEUTICS Corp (UTHR)
ROTHBLATT MARTINE A — Director
Shares
200
Price
$486.77
Total Value
$97.35K
Shares Held After
324,443
% of Holdings
0.1%
UNITED THERAPEUTICS Corp (UTHR)
ROTHBLATT MARTINE A — Director
Shares
120
Price
$482.28
Total Value
$57.87K
Shares Held After
324,643
% of Holdings
0.0%
UNITED THERAPEUTICS Corp (UTHR)
ROTHBLATT MARTINE A — Director
Shares
500
Price
$481.22
Total Value
$240.61K
Shares Held After
324,763
% of Holdings
0.2%
UNITED THERAPEUTICS Corp (UTHR)
ROTHBLATT MARTINE A — Director
Shares
160
Price
$479.59
Total Value
$76.73K
Shares Held After
325,263
% of Holdings
0.0%
UNITED THERAPEUTICS Corp (UTHR)
ROTHBLATT MARTINE A — Director
Shares
1,200
Price
$479.07
Total Value
$574.89K
Shares Held After
325,423
% of Holdings
0.4%
UNITED THERAPEUTICS Corp (UTHR)
ROTHBLATT MARTINE A — Director
Shares
2,309
Price
$478.10
Total Value
$1.10M
Shares Held After
326,623
% of Holdings
0.7%
UNITED THERAPEUTICS Corp (UTHR)
ROTHBLATT MARTINE A — Director
Shares
2,135
Price
$477.09
Total Value
$1.02M
Shares Held After
328,932
% of Holdings
0.6%
UNITED THERAPEUTICS Corp (UTHR)
ROTHBLATT MARTINE A — Director
Shares
1,395
Price
$476.10
Total Value
$664.16K
Shares Held After
331,067
% of Holdings
0.4%
UNITED THERAPEUTICS Corp (UTHR)
ROTHBLATT MARTINE A — Director
Shares
552
Price
$475.12
Total Value
$262.26K
Shares Held After
332,462
% of Holdings
0.2%
UNITED THERAPEUTICS Corp (UTHR)
ROTHBLATT MARTINE A — Director
Shares
80
Price
$473.86
Total Value
$37.91K
Shares Held After
333,014
% of Holdings
0.0%
UNITED THERAPEUTICS Corp (UTHR)
ROTHBLATT MARTINE A — Director
Shares
449
Price
$472.97
Total Value
$212.36K
Shares Held After
333,094
% of Holdings
0.1%
UNITED THERAPEUTICS Corp (UTHR)
ROTHBLATT MARTINE A — Director
Shares
400
Price
$472.05
Total Value
$188.82K
Shares Held After
333,543
% of Holdings
0.1%
Kodiak Sciences Inc. (KOD)
BAKER BROS. ADVISORS LP — Director
Shares
1,416
Price
$85.89
Total Value
$121.61K
Shares Held After
20,191,214
% of Holdings
0.0%
Showing 51–100 of 298 transactions (page 2 of 6)